A Study to Evaluate Coronary Atherosclerosis in Patients With Diabetes Mellitus
Recruiting now
Conditions studied: Diabetes Mellitus
In brief
The purpose of this study is to evaluate the natural history of coronary atherosclerosis development and progression over time by CCTA and to identify risk factors attributable to the development of coronary atherosclerosis in a Korean DM population.
Key facts
- Study ID
- NCT05801432
- Run by
- Asan Medical Center
- People needed
- 511
- Starts
- 2021-08-24
- Expected to finish
- 2026-12-31
- Last updated by the study team
- 2026-03-30
Who can join
Age: 19 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Age 19 years or older
- Asymptomatic patients with type 2 DM who had undergone initial CCTA evaluation at the Diabetes Center of the Asan Medical Center between February 2008 and June 2012
- Willing and able to provide informed written consent
You may not qualify if…
- Blood test results that the Creatinine level exceeds 1.5 mg/dL
- A person with a history of anaphylaxis or allergic shock associated with a contrast medium
- Pregnant women
- Unable to undergo follow-up CCTA
- Uninterpretable CCTA
Where it is running
- Asan Medical Center — Seoul, South Korea (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.